Challenges in proliferative vitreoretinopathy: is biological therapy a solution?

Lorenzo Ferro Desideri^{1

2

3}, Souska Zandi^{1

2

3}, Martin S Zinkernagel^{1

2

3}, Rodrigo Anguita^{1

2

4}

Affiliations

¹ Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
² Department for BioMedical Research, University of Bern, Bern, Switzerland.
³ Bern Photographic Reading Center, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
⁴ Vitreoretinal department, Moorfields Eye Hospital NHS Foundation Trust, London, UK.

Editorial

Lorenzo Ferro Desideri et al. Expert Opin Biol Ther. 2023 Jul-Dec.

. 2023 Jul-Dec;23(10):937-939.

doi: 10.1080/14712598.2023.2248881. Epub 2023 Aug 18.

Lorenzo Ferro Desideri^{1

2

3}, Souska Zandi^{1

2

3}, Martin S Zinkernagel^{1

2

3}, Rodrigo Anguita^{1

2

4}

¹ Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
² Department for BioMedical Research, University of Bern, Bern, Switzerland.
³ Bern Photographic Reading Center, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
⁴ Vitreoretinal department, Moorfields Eye Hospital NHS Foundation Trust, London, UK.

No abstract available

Keywords: PVR; PVR classification; Proliferative vitreoretinopathy; corticosteroids; methotrexate; therapeutic challenges.

Publication types